compounding pharmacies

R&D

pharmaphorum podcast Episode 223, Shawn Hodges, Revelation Pharma

On US drug shortages and compounding pharmacies, with Shawn ...

Shawn Hodges, CEO of Revelation Pharma, discusses the true state of drug shortages in the US at the moment and the role of compounding pharmacies.

R&D

The importance of understanding the differences between 503A...

Inside the ecosystem of compounding pharmacies, 503A and 503B facilities are distinct.

News

FDA lends a hand to Novo, Lilly on illegal GLP-1 imports

The FDA has set up a green list of overseas sources for GLP-1 ingredients to try to block imports of illegitimate and potentially unsafe materials.

News

Noom Med app and accompanying GLP-1 implements

Noom expands its GLP-1 range with 'microdose' package

Noom is offering 'microdoses' of semaglutide at a knock-down price, claiming they can prevent side effects but remain effective for weight loss.

News

Compounders cast adrift after semaglutide shortage ends

The FDA has said there is no longer a shortage in the US market for Novo Nordisk's GLP-1 agonist semaglutide, ending sales of compounded forms.

News

Pharma group slams Hims & Hers over Super Bowl GLP-1 ad

Partnership for Safe Medicines claims the Hims & Hers ad for compounded weight-loss drug semaglutide, due to run during the Super Bowl, is "reckless."

On US drug shortages and compounding pharmacies, with Shawn ...

The importance of understanding the differences between 503A...

FDA lends a hand to Novo, Lilly on illegal GLP-1 imports

Noom expands its GLP-1 range with 'microdose' package

Compounders cast adrift after semaglutide shortage ends

Pharma group slams Hims & Hers over Super Bowl GLP-1 ad

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

compounding pharmacies

Editor's Picks